Cover Image

Molecular targeting therapy with angiotensin II receptor blocker for prostatic cancer

Hiroji Uemura, Hitoshi Ishiguro, Yoshinobu Kubota
  • Hitoshi Ishiguro
    Department of Urology, Yokohama City University Graduate School of Medicine, Yokohama, Japan
  • Yoshinobu Kubota
    Department of Urology, Yokohama City University Graduate School of Medicine, Yokohama, Japan

Abstract

Angiotensin II (Ang-II) plays a key role as a vasoconstrictor in controlling blood pressure and electrolyte/fluid homeostasis. Recently it has also been shown that this peptide is a cytokine, acting as a growth factor in cardiovascular and stromal cells. In addition, the physiological function of Ang-II seems to be similar in prostate cancer and stromal cells. It is widely assumed that Ang-II facilitates the growth of both cells, and its receptor blockers (ARBs) have the potential to inhibit the growth of various cancer cells and tumors through the Ang-II receptor type 1 (AT1 receptor). The mechanism of cell growth inhibition by ARBs has been considered to be that of suppression of the signal transduction systems activated by growth factors or cytokines in prostate cancer cells, and suppression of angiogenesis. This review highlights the possible use of ARBs as novel agents for prostatic diseases including prostate cancer and benign hypertrophy, and covers related literature.

Keywords

Angiotensin II - Angiotensin II receptor blocker - Prostate cancer

Full Text

FULL TEXT
Submitted: 2011-12-18 11:11:37
Published: 2011-12-18 00:00:00
Search for citations in Google Scholar
Related articles: Google Scholar
Abstract views:
614

Views:
FULL TEXT
262

Article Metrics

Metrics Loading ...

Metrics powered by PLOS ALM


Copyright (c) 2011 Hiroji Uemura, Hitoshi Ishiguro, Yoshinobu Kubota

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
 
© PAGEPress 2008-2017     -     PAGEPress is a registered trademark property of PAGEPress srl, Italy.     -     VAT: IT02125780185